Literature DB >> 22993548

Role of inhibitor of DNA binding-1 protein is related to angiogenesis in the tumor advancement of uterine endometrial cancers.

Min Khine Maw1, Jiro Fujimoto, Teruhiko Tamaya.   

Abstract

The inhibitor of DNA binding (ID)-1 protein, an inhibitor of basic helix-loop-helix transcription factors, has been found to be involved in multiple cellular functions. In the present study, ID-1 histoscores and mRNA levels were both significantly (p<0.05) increased in uterine endometrial cancers according to clinical stage, histological grade and depth of myometrial invasion. Furthermore, the 60-month survival rate of the 25 patients with high ID-1 was poor (52%), while that of the other 25 patients with low ID-1 was significantly higher (80%) (p<0.05). ID-1 histoscores and mRNA levels significantly (p<0.0001) correlated with microvessel counts in uterine endometrial cancers. Therefore, ID-1 acts on tumor advancement via angiogenic activity and can be considered a candidate prognostic indicator in uterine endometrial cancers.

Entities:  

Year:  2010        PMID: 22993548      PMCID: PMC3445945          DOI: 10.3892/etm_00000055

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  28 in total

1.  Id-1 expression promotes cell survival through activation of NF-kappaB signalling pathway in prostate cancer cells.

Authors:  Ming-Tat Ling; Xianghong Wang; Xue-Song Ouyang; Kexin Xu; Sai-Wah Tsao; Yong-Chuan Wong
Journal:  Oncogene       Date:  2003-07-17       Impact factor: 9.867

2.  Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts.

Authors:  D Lyden; A Z Young; D Zagzag; W Yan; W Gerald; R O'Reilly; B L Bader; R O Hynes; Y Zhuang; K Manova; R Benezra
Journal:  Nature       Date:  1999-10-14       Impact factor: 49.962

3.  A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells.

Authors:  C Q Lin; J Singh; K Murata; Y Itahana; S Parrinello; S H Liang; C E Gillett; J Campisi; P Y Desprez
Journal:  Cancer Res       Date:  2000-03-01       Impact factor: 12.701

4.  Id-1 and Id-2 are overexpressed in pancreatic cancer and in dysplastic lesions in chronic pancreatitis.

Authors:  H Maruyama; J Kleeff; S Wildi; H Friess; M W Büchler; M A Israel; M Korc
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

5.  Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies.

Authors:  K S McCarty; L S Miller; E B Cox; J Konrath; K S McCarty
Journal:  Arch Pathol Lab Med       Date:  1985-08       Impact factor: 5.534

6.  Regulation of cyclin expression and cell cycle progression in breast epithelial cells by the helix-loop-helix protein Id1.

Authors:  Alexander Swarbrick; Mia C Akerfeldt; Christine S L Lee; C Marcelo Sergio; C Elizabeth Caldon; Lisa-Jane K Hunter; Robert L Sutherland; Elizabeth A Musgrove
Journal:  Oncogene       Date:  2005-01-13       Impact factor: 9.867

7.  Level of Id-1 protein expression correlates with poor differentiation, enhanced malignant potential, and more aggressive clinical behavior of epithelial ovarian tumors.

Authors:  Monika Schindl; Sebastian F Schoppmann; Thomas Ströbel; Harald Heinzl; Christina Leisser; Reinhard Horvat; Peter Birner
Journal:  Clin Cancer Res       Date:  2003-02       Impact factor: 12.531

8.  Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis.

Authors:  Sylvia Fong; Yoko Itahana; Tomoki Sumida; Jarnail Singh; Jean-Philippe Coppe; Yong Liu; Peter C Richards; James L Bennington; Nancy M Lee; Robert J Debs; Pierre-Yves Desprez
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-24       Impact factor: 11.205

9.  Expression of the inhibitor of DNA-binding (ID)-1 protein as an angiogenic mediator in tumour advancement of uterine cervical cancers.

Authors:  M K Maw; J Fujimoto; T Tamaya
Journal:  Br J Cancer       Date:  2008-10-28       Impact factor: 7.640

10.  Id-1 and Id-2 are markers for metastasis and prognosis in oesophageal squamous cell carcinoma.

Authors:  H-F Yuen; Y-P Chan; K-K Chan; Y-Y Chu; M L-Y Wong; S Y-K Law; G Srivastava; Y-C Wong; X Wang; K-W Chan
Journal:  Br J Cancer       Date:  2007-11-13       Impact factor: 7.640

View more
  3 in total

1.  Increased expression of Id1 and Id3 promotes tumorigenicity by enhancing angiogenesis and suppressing apoptosis in small cell lung cancer.

Authors:  Danqing Chen; Shiva S Forootan; John R Gosney; Farzad S Forootan; Youqiang Ke
Journal:  Genes Cancer       Date:  2014-05

2.  Uterine double-conditional inactivation of Smad2 and Smad3 in mice causes endometrial dysregulation, infertility, and uterine cancer.

Authors:  Maya Kriseman; Diana Monsivais; Julio Agno; Ramya P Masand; Chad J Creighton; Martin M Matzuk
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-16       Impact factor: 11.205

3.  Inflammatory properties of inhibitor of DNA binding 1 secreted by synovial fibroblasts in rheumatoid arthritis.

Authors:  Gautam Edhayan; Ray A Ohara; W Alex Stinson; M Asif Amin; Takeo Isozaki; Christine M Ha; G Kenneth Haines; Rachel Morgan; Phillip L Campbell; Ali S Arbab; Sean C Friday; David A Fox; Jeffrey H Ruth
Journal:  Arthritis Res Ther       Date:  2016-04-12       Impact factor: 5.156

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.